Letter to the editor - "Re: Tinea labialis in a patient with Schnitzler syndrome on interleukin-1 receptor antagonist".
Velusamy B, Pincelli T, Sokumbi O
JAAD Case Rep · 2025
Grade Dletter
Key Findings
- ●Expert commentary from Mayo Clinic dermatologists on anakinra-associated fungal infection risk
- ●Contextualises tinea labialis as rare but clinically important opportunistic infection during IL-1 blockade
- ●Supports surveillance for dermatophyte infections in Schnitzler syndrome patients on IL-1 inhibitors
Referenced in (1 disease)
ID: pmid-41542300DOI: 10.1016/j.jdcr.2025.10.071PMID: 41542300